Live Breaking News & Updates on Kaneka probiotics division
Stay updated with breaking news from Kaneka probiotics division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kaneka Probiotics launches L. plantarum DR7 for immune support Texas-based Kaneka Probiotics has launched Lactobacillus plantarum DR7 for immune support supplements, with the strain’s efficacy supported by clinical trials. The DR7 strain was isolated originally from fresh bovine milk, and its potential benefits respiratory health were reported in a randomized-controlled clinical trial published in the Journal of Dairy Science*. The study included 109 adults randomly assigned to receive either one billion CFUs of DR7 per day or placebo for 12 weeks. The data indicated that the probiotic was associated with decreased levels of pro-inflammatory cytokines such as TNF-alpha and IFN-gamma in the subjects, as well as reduced the duration of nasal symptoms.